Kemtai's markerless motion assessments and AI-guided exercises help life sciences companies differentiate clinical outcomes, qualify patients with objective movement biomarkers, and drive the adherence that unlocks the full impact of your therapy or device while generating real-world evidence at scale.
Enhance Your Clinical Value
Expand Market Share
Increase identification of eligible patients with scalable motion assessments
Differentiate Your Outcomes
Drive superior rehabilitation or exercise adherence through AI-guided movement with real-time feedback
Generate RWE
Generate insights for post-market surveillance, marketing, and regulatory submissions with real-world motion data
Optimize Intervention Timing
Use motion-based biomarkers to monitor disease progression and transition patients to the next line of therapy at the ideal clinical moment
Enhance Patient Loyalty and Safety
Provide a digital companion to support recovery and treatment adherence
Sample Use Cases
Surgical implant recovery and monitoring
Therapy escalation screening
GLP-1 and weight management support
Movement disorders
Neurodegenerative disease monitoring
Decentralized clinical trial endpoints
“Beyond the pill” support and rehab adherence
Key Capabilities
Accuracy scientifically validated against 3D motion labs
Objective digital movement assessments and biomarkers